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Background: The aim of this retrospective observational study was to describe thyroid function parameters
(fT3, fT4 and TSH) in the course of normal pregnancies.
Methods: Data were obtained between 2006 and 2007 at the University Hospital in Innsbruck, Austria. The
starting point was the identiﬁcation of women who had had a normal birth as recorded in the birth registry of
Tyrol. Thyroid function parameters were determined usingmethods implemented at the Department of Nuclear
Medicine in Innsbruck.
Results: The fT3 and fT4 values were normally distributed. Grouping the results by trimester revealed the
following values: 4.93 ± 0.59, 4.54 ± 0.48, and 4.27 ± 0.45 pmol/l for fT3; and 15.23 ± 2.43, 13.79 ± 1.99,
and 13.32 ± 0.2.01 pmol/l for fT4, respectively. The values corresponding to the 10th-percentile were 3.9
pmol/l for fT3 and 11.3 pmol/l for fT4, respectively. TSH values showed a typical left skewed distribution, thus
the mean values were calculated after log transformation of the data. The corresponding mean trimestral values
for TSH were 1.46 ± 1.29, 1.68 ± 1.23, and 1.70 ± 2.22 mIU/l, respectively.
Conclusion: In an iodine sufﬁcient population, thyroid function parameters in normal pregnancies do not differ
from those in non-pregnant women. Our previously deﬁned reference range for TSH of 0.3 to 3.5mIU/l is equally
valid for normal pregnancies.
General signiﬁcance: The question of cognition and IQ development of children has been proposed to be
associated with thyroid function. The addition of data regarding normal thyroid function during pregnancy
will contribute to this research.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The role of thyroid function during pregnancy has been observed
and described since many centuries [1]. Modern studies describe
thyroid disease as the second most frequent endocrine disorder that
can affect women in their reproductive age. When thyroid disease
remains untreated in a pregnant woman some disorders can appear.
These include risk of miscarriage, hypertension, growth restriction,
and placental abruption [2]. One fundamental cause of thyroid dysfunc-
tion is iodinedeﬁciencywhichwill lead to the development of goiter [3]., free triiodothyronine; fT4, free
edicine, Medical University of
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. This is an open access article underWhen iodine deﬁciency is present together with obstetrical pathology
the cognitive development of the offspring can be endangered [4].
Fierro-Benítez et al. added the factor of protein–caloric malnutrition in
regulating mental development [5]. The putative negative effect of
thyroid function on cognitive development, however, has not been
conﬁrmed in a recent study [6].
The regulation of thyroid function has been analyzed from a
historical point of view by Toni [7]. Current descriptions place thyroid
hormone action and regulation in the context of regulation of metabo-
lism [8]. The cellular processes leading to thyroid hormone action
require selenoproteins, the deiodinases [9], in order to convert the
pro-hormone T4 to the active form T3 [10].
In the clinical setting the evaluation of thyroid function relies on
morphological and laboratory methods. In the past years we have
been involved in applying improved thyroid ultrasound techniques
[11] as well as in evaluating thyroid hormone reference levels in chil-
dren and adults [12,13] under conditions of sufﬁcient iodine supply.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Thyroid function reference values for fT3, fT4, TSH and fT3/fT4 ratio across pregnancy.
Pregnancy fT3
pmol/l
fT4
pmol/l
TSH
mIU/l
fT3/fT4
Week Mean S.D. Mean S.D. Mean S.D. Mean
6 4.55 0.35 14.45 0.35 1.57 0.63 0.31
7 5.06 0.68 15.30 2.63 2.22 1.45 0.33
8 5.08 0.64 16.03 2.99 1.33 0.97 0.32
9 5.04 0.57 15.35 3.32 1.48 2.33 0.33
10 5.03 0.75 15.75 2.67 0.96 0.76 0.32
11 4.89 0.59 14.89 2.79 1.21 1.12 0.33
12 4.89 0.56 14.84 2.26 1.41 1.75 0.33
13 4.78 0.64 14.72 2.58 1.65 1.96 0.32
14 4.75 0.56 14.02 1.88 1.52 1.23 0.34
15 4.69 0.45 14.02 2.04 1.57 1.01 0.33
16 4.66 0.54 14.02 1.89 1.67 1.58 0.33
17 4.54 0.44 14.03 2.19 1.61 0.89 0.32
18 4.55 0.45 13.23 1.66 1.91 2.28 0.34
19 4.61 0.50 13.86 2.19 1.90 1.06 0.33
20 4.39 0.40 13.19 1.83 1.83 1.26 0.33
21 4.52 0.46 13.83 1.91 1.63 0.94 0.33
22 4.38 0.48 13.69 2.16 1.70 0.98 0.32
23 4.31 0.45 13.43 1.96 1.70 0.86 0.32
24 4.33 0.45 13.39 1.62 1.41 0.79 0.32
25 4.31 0.48 13.17 2.07 1.77 1.32 0.33
26 4.21 0.54 13.29 2.32 2.77 10.97 0.32
27 4.30 0.43 13.07 2.47 1.49 0.92 0.33
28 4.25 0.40 13.33 1.80 1.44 0.98 0.32
29 4.28 0.42 13.33 1.93 1.72 1.56 0.32
30 4.26 0.41 13.90 1.78 1.32 0.65 0.31
31 4.34 0.48 12.97 2.04 1.44 0.92 0.33
32 4.35 0.46 13.32 1.93 1.60 0.95 0.33
33 4.23 0.41 13.63 2.25 1.55 1.16 0.31
34 4.27 0.55 13.14 1.86 2.10 5.36 0.32
35 4.23 0.44 13.24 1.86 1.58 0.82 0.32
36 4.24 0.40 13.46 1.87 1.57 1.03 0.31
37 4.25 0.43 13.12 2.32 1.56 0.96 0.32
38 4.29 0.39 12.82 1.43 1.68 0.93 0.33
39 4.18 0.42 13.60 1.78 1.89 1.03 0.31
40 4.04 0.32 12.56 2.70 1.74 1.04 0.32
41 3.97 0.49 13.23 0.76 2.29 0.58 0.30
Total mean 4.47 0.48 13.81 2.06 1.66 1.53 0.32
Fig. 1. Normal distribution of fT3 values in normal pregnancies.
91R. Moncayo et al. / BBA Clinical 3 (2015) 90–95The aim of the present study was to analyze thyroid function parame-
ters in normal pregnancies.
2. Materials and methods
2.1. Patients
This study was carried out at the University Hospital in Innsbruck,
Austria between 2006 and 2007. The study was conceived by KH who
had previously designed and implemented the Tyrolean Birth Registry
(Registry). The investigation was conducted as a retrospective case
study of women that had a normal pregnancy. The data regarding the
uneventful course of the pregnancy were obtained from the Registry.
Inclusion criteria were that all babies born were healthy with no
obstetrical pathology (data not shown). After identifying the subjects,
thyroid function parameters as well as pregnancy variables were
retrieved from the hospital clinical database. The study was approved
by the local Ethics Committee.
2.2. Laboratory methods
Thyroid function parameters were determined using routine
methods implemented at the Department of Nuclear Medicine as
described previously [14]. Reference values for TSH have been described
by us before [12] and served as a control group. A total of 2028 data sets
were available for TSH evaluation and 1822 for fT3 and fT4. Laboratory
determinationswere performed on an ADVIA Centaur XP Immunoassay
System (Siemens, Erlangen, Germany). Assay performance characteris-
tics are similar to those reported by Reix et al. [15].
2.3. Statistical methods
The same subject was studied up to 3 times during pregnancy. Data
was grouped according to the week of pregnancy. At each week of
pregnancy a descriptive data analysis for fT3, fT4, and TSH was done.
Presentation of the results for fT3 and fT4 was done by depicting the
conﬁdence intervals. TSH values are shown in percentiles. Statistical
analysis was done with IBM SPSS 22.
3. Results
The mean age of the subjects was 27.6 ± 6.2 years. Among the
subjects studied, we observed 5 cases of hypothyroidism, 10 cases of
hyperthyroidism, and 159 cases of latent hyperthyroidism. In 83 cases
a latent hypothyroidism was detected having 95% CI values of TSH
between 4.5 and 5.3 mIU/l. These cases were subsequently excluded
from the analysis. In spite of thyroid dysfunction these women had a
normal pregnancy and delivery.
The results of the study are presented in Table 1 showing the mean
and S.D. for each parameter according to pregnancyweek. These results
are extracted giving the mean values for 3 periods of time: up to week
12, weeks 13 to 24, and weeks 25 to 36. The corresponding trimestral
values for fT3 were 4.93 ± 0.59, 4.54 ± 0.48, and 4.27 ± 0.45 pmol/l,
respectively. The corresponding trimestral values for fT4 were
15.23 ± 2.43, 13.79 ± 1.99, and 13.32 ± 2.01 pmol/l, respectively.
Both parameters showed a continuous decline. The fT3 to fT4 ratio
had a mean value of 0.32. The values corresponding to the 10th-
percentile were 3.9 pmol/l for fT3 and 11.3 pmol/l for fT4, respectively.
Figs. 1 and 2 show the histograms depicting the normal distribution of
fT3 and fT4; Figs. 3 and 4 show the course of fT3 and fT4 during
pregnancy.
TSH values showed a typical left skewed distribution. The mean
values were calculated after log transformation of the data. The corre-
sponding mean trimestral values for TSH were 1.46 ± 1.29, 1.68 ±
1.23, and 1.70 ± 2.22 mIU/l, respectively. The maximal values reached
levels of 3.5 mIU/l. Fig. 5 shows the TSH values at the percentile levelsof 2.5, 5.0, 50.0, 95, and 97.5 across pregnancy.While TSH levels showed
little variation, only those corresponding to the 2.5 and 5.0 percentiles
decreased between weeks 6 and 8 of pregnancy.
4. Discussion
This clinical observational study demonstrates that under conditions
of sufﬁcient iodine supply women that have a normal pregnancy
Fig. 2. Normal distribution of fT4 values in normal pregnancies. Fig. 4. The course of fT4 levels through pregnancy.
92 R. Moncayo et al. / BBA Clinical 3 (2015) 90–95present thyroid function parameters similar to those found in a normal
adult population. The key message of our study is that TSH levels range
between 0.3 and 3.5mIU/l. These results indicate that it is not necessary
to rely on so-called pregnancy-speciﬁc evaluations, nor on consensus
recommendations.
4.1. Questioning the use of recommended reference values
The negative impact of relying on “recommendations” for the inter-
pretation of thyroid laboratory results has been recently commented by
us as: “lack of clinical congruence” [16]. By this wemean amisclassiﬁca-
tion of subjects by using an arbitrary cut-off value. This concern appears
to be shared by other authors. Vila et al. discussed the impact of using an
upper reference value for TSH of 2.5 mIU/ml and added that such a
measure has: “…raised concern among clinicians and it has been argued
that it would result in classifying healthy pregnant women as having a
pathological disease” (page R25 in [17]). Moreover, a recent publication
failed to show differences in the frequency of thyroid pathology found
inpregnantwomenwhen these recommendedvalues areused (Tables 3
and 4 in [18]). In relation to outcome of pregnancy, Hirsh et al. have
recently shown that TSH values much higher than 2.5 mIU/ml do not
appear to be related to altered outcome of pregnancies [19]. Similarly,
Taylor et al. reported recently that TSH levels up to 4.5 mIU/l did not
lead to the identiﬁcation of patients with elevated miscarriage risk
[20]. Similar observations have also been made within the ﬁeld of
in vitro fertilization. Reh and coworkers have also looked critically at
this “desirable” TSH level [21]. They concluded that an increasing
number of subjects would be falsely classiﬁed as being hypothyroid. InFig. 3. The course of fT3 levels through pregnancy.2007 Spandorfer et al. reported a lack of difference in IVF outcome
when TSH levels lower and higher than 4 mIU/l were taken as discrim-
inators. The same result was observed when TSH levels lower or higher
than 2.5 mIU/l were considered [22].
In daily practice, we (HM and RM) have had repeated referrals of
pregnant and non-pregnant women who supposedly have high TSH
values. This misinterpretation of thyroid function parameters originates
from a publication in 2007 [23]. It is of utmost importance to note that
the authors of the publication in question admitted that there is a
poor level of evidence for their recommendation to consider an upper
value of TSH of 2.5 mIU/l as a “desirable level”. In order to increase
the level of evidence, the recommendations given by the Grading of
Recommendation, Assessment, Development, and Evaluation (GRADE)
Working Group [24] should be observed. One can read in this publica-
tion the following statement: “Recommendationsmust apply to speciﬁc
settings and particular groups of patients whenever the beneﬁts and
harms differ across settings or patient groups” (page 1491 in [24]). It
follows that in the ﬁeld of thyroid diseases reference values have to be
put ﬁrst into the context of iodine supply, i.e. iodine deﬁcient or iodine
sufﬁcient population, and then into the clinical context (age, sex,
pregnancy, obstetrical ﬁndings).
4.2. Confounding factors related to thyroid function in pregnancy
Investigations performed at the end of the previous century did not
meet the abovementioned criteria. Work which began in 1988 by
Belgian researchers on thyroid function in pregnancy introduced biasFig. 5. TSH values at the percentile levels of 2.5, 5.0, 50.0, 95, and 97.5 during pregnancy.
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93R. Moncayo et al. / BBA Clinical 3 (2015) 90–95by studying a population with iodine deﬁciency aswell as subjects with
obstetrical pathology [25]. While iodine supplementation programs
have been initiated worldwide for many decades, the data presented
by Vitti in 2003 demonstrated that iodine deﬁciency has still not been
eliminated in Europe [26]. Even mild iodine deﬁciency led to thyroid
disorders in 2012–2013 in countries including Belgium, France, and
the U.K. [27–29]. Irrespective of historical descriptions that relate hypo-
thyroidism during pregnancy to altered IQ of the offspring [30], investi-
gation of thyroid function in pregnancy remains amatter of interest. In a
study published in 2012 that investigated the cognitive development of
the offspring, iodine deﬁciency was still a confounding variable [6,31].
However, the authorswere unable to demonstrate that treatment of hy-
pothyroidism with thyroxine improved cognitive function of the chil-
dren at age 3 years. Other investigators have proposed that additional
mechanisms, i.e. prematurity, could play a role as determinants of intel-
ligence [32]. Not only reports on TSH levels can be conﬂicting but also
the evaluation of the percentile distribution of fT4 can show different
results. In 1999 Pop et al. investigated an iodine sufﬁcient population
and calculated the 10th percentile for fT4 [33]. Their values are much
lower than those obtained in the study herein. This difference implies
that other factors inﬂuence thyroid economy. A similar observation
was made when the ratio between fT3 and fT4 was evaluated. While
the data obtained in the present study revealed quite constant values
(mean 0.32) the results presented by Bassols et al. are quite different
[34].
Another issue that is related to pregnancy and iodine deﬁciency is
that of an apparent decrease in TSH levels during early pregnancy.
This was originally described in a series of 8 women with iodine
deﬁciency [35]. A similar ﬁnding was subsequently reported in the
Belgian studies [25]. Some years later this hypothesis was published
again and presented in a graphical form that depicted a decrease in
TSH concentration whereas hCG values were high (Fig. 1 in [36]). This
publication also reported an increase in fT4 during early pregnancy. A
modern evaluation of the association between hCG and TSH concluded
that in most pregnant women this relationship is weak [37]. However,
the authors could identify a stronger relationship between hCG and
TSH for TSH values in the lower centiles. Our results show a similar
situation. Thus, the data indicate that a decrease in TSH levels during
pregnancy is not a general phenomenon. In addition, the data presented
herein do not support the notion that fT4 levels increase during early
pregnancy as reported by Burrow [36]. Tables 2 and 3 summarize the
results and methods of studies that have evaluated thyroid function in
pregnant women.
Recently (2014) we have observed a negative interaction arising
from multivitamin preparations prescribed for pregnant women (n =
25). These preparations contain 200 to 220 μg iodine per tablet or
capsule. The patients presented latent to overt hyperthyroidism
although on ultrasound thyroid morphology was normal. We interpret
this situation as an iodine-induced hyperthyroidism. After stopping
the intake of these preparations thyroid function has returned to
normal.
In summary, the lack of a validated system for laboratory results
based on speciﬁc clinical traits damages the principles of evidence-
based diagnostics [38]. Declaring that a euthyroid woman has thyroid
disease or advocating treatment for a condition that most likely does
not exist is not in keeping with good medical approach. An equivocal
diagnosis only makes patients feel insecure, thus adding to psychologi-
cal stress, which is already frequently observed in hypothyroidism [39,
40]. In times when unduly conduct is being reported every day in the
media, we should remember that: “By not reporting poor care ….
individuals clearly failed in their professional responsibility to protect
patients” [41]. In view of faulty clinical work found in the scientiﬁc
literature, Yong, Ledford, and Van have published a stimulating paper
entitled: “Research ethics: 3ways to blow thewhistle” [42]. Considering
that clinical work should be as accurate as possible, these recommenda-
tions are inspiring.
Table 3
Methodologies used for the determination of thyroid function parameters in pregnancy.
Author fT3 fT4 TSH
Cotzias [43] ADVIA Centaur competitive immunoassay ADVIA Centaur competitive immunoassay ADVIA Centaur two-side sandwich immunoassay
Soldin [44] Immunoassay (ROCHE) Chemiluminescence immunometric assay
(Nichols Institute Diagnostics)
Marwaha [45] Electrochemiluminescence system — Elecsys 1010 Analyzer (ROCHE Diagnostics, Germany)
Springer [46] Chemiluminometric immunoanalysis Chemiluminometric immunoanalysis
Karakosta [47] Immunoassay system (IMMULITE 2000, Siemens)
Ekinci [48] Chemiluminescent immunoassay using a Beckman DXL 800 Analyzer
Azizi [49] Immunoassay system Immunoassay system
Moreno-Reyes [28] Third generation chemiluminescence immunoassay (ROCHE)
94 R. Moncayo et al. / BBA Clinical 3 (2015) 90–955. Conclusion
We conclude that the use of thyroid function reference values based
on studies using different populations and different backgrounds can
introduce bias in the evaluation of a local cohort. Three main factors
should be considered: iodine supply, obstetrical pathology and the
laboratory methodology. In our population, TSH values are within a
range comparable to TSH values of normal adults determined using
the same methodology [12–14]. We believe that our data are of direct
relevance for clinicians working in a similar environment, i.e. iodine
sufﬁciency and with a similar laboratory system.
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